Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Michael P. Rubin reported a 6.10% stake in Kyverna Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Michael P. Rubin reported a 6.10% stake in Kyverna Therapeutics, Inc., 3,466,826 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 6.10%
- Shares
- 3,466,826
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Northpond Ventures III, LP | 4.90% | 2,805,426 |
| Northpond Ventures III GP, LLC | 4.90% | 2,805,426 |
| Northpond Ventures, LP | 0.80% | 450,000 |
| Northpond Ventures GP, LLC | 0.80% | 450,000 |
| NPV Listed, LLC | 0.40% | 211,400 |
| Northpond Ventures, LLC | 0.40% | 211,400 |
| Michael P. Rubin | 6.10% | 3,466,826 |
Source
Related
- Kyverna Therapeutics, Inc.
- Michael P. Rubin
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Cohen Fred E · May 29, 2026